ARTIDIS is a clinical-stage health technology company that has developed the first nanomechanical biomarker for cancer diagnosis and treatment optimization. Its work sits at the intersection of nanotechnology, atomic force microscopy, and biomarker analysis, operating within the healthcare, oncology, and clinical diagnostics verticals.
The company’s product, ARTIDISNET, is a digital platform that integrates various types of clinical data. It is designed to help physicians shorten the diagnostic process and design personalized cancer treatment plans.
ARTIDIS has a geographic presence in Basel, Switzerland, as well as operations in the USA, Spain, and Croatia.
